rs876657865
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145309.4(LRTOMT):āc.53A>Cā(p.Asp18Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000286 in 1,399,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001145309.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRTOMT | NM_001145309.4 | c.53A>C | p.Asp18Ala | missense_variant | 6/9 | NP_001138781.1 | ||
LRTOMT | NM_001145308.5 | c.53A>C | p.Asp18Ala | missense_variant | 4/7 | NP_001138780.1 | ||
LRTOMT | NM_001145310.4 | c.53A>C | p.Asp18Ala | missense_variant | 6/9 | NP_001138782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000645 AC: 1AN: 155126Hom.: 0 AF XY: 0.0000122 AC XY: 1AN XY: 82240
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1399318Hom.: 0 Cov.: 31 AF XY: 0.00000290 AC XY: 2AN XY: 690168
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 22, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Asp18Ala vari ant in LRTOMT has not been previously reported in individuals with hearing loss or in large population studies. Computational prediction tools and conservation analyses suggest that the p.Asp18Ala variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the Asp18Ala variant is uncertain, these dat a suggest that it is more likely to be benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at